Evidence map›Paper›PMID 34307120›Full record

ReviewFrontiers in oncology2021

Visualized Analysis of Heavy Ion Radiotherapy: Development, Barriers and Future Directions.

Yuanchang Jin, Jingwen Li, Jieyun Li, Na Zhang, Kangle Guo, Qiuning Zhang, Xiaohu Wang, Kehu Yang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yuanchang JinEvidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
Jingwen LiEvidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
Jieyun LiEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Na ZhangEvidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
Kangle GuoEvidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
Qiuning ZhangHeavy Ion Treatment Center, Lanzhou Heavy Ions Hospital, Lanzhou, China.
Xiaohu WangHeavy Ion Treatment Center, Lanzhou Heavy Ions Hospital, Lanzhou, China.
Kehu YangEvidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
Lanzhou University · CNChinese Academy of Sciences · CNInstitute of Modern Physics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeavy ion radiotherapy (HIRT) has great advantages as tumor radiotherapy.

methodsBased on 1,558 literatures from core collections of Web of Science from 1980 to 2020, this study visually analyzes the evolution of HIRT research, and sorts out the hotspots and trends of HIRT research using CiteSpace software.

resultsResearch on HIRT has received more extensive attention over the last 40 years. The development of HIRT is not only closely related to radiation and oncology, but also closely related to the development of human society. In terms of citation frequency, "International Journal of Radiation Oncology*Biology*Physics" was the top journal. In terms of influence, "Radiotherapy and Oncology" was the top journal. "Radiation therapy" and "carbon ion radiotherapy" were the two most frequently used keywords in this field.

conclusionThe evolution of the HIRT research has occurred in approximately three stages, including technological exploration, safety and effectiveness research and technological breakthroughs. Finally, some suggestions for future research are put forward.

Indexed as

cancerCitespaceheavy ion radiotherapyradiationvisualization research

Identifiers

PMID34307120
PMCPMC8300564
OpenAlexW3181127609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.